On January 5, 2026, GE HealthCare Technologies Inc. received an unsolicited mini-tender offer from Potemkin Limited to purchase up to 100,000 common shares at a price that represents approximately a 34.8% discount to GE HealthCare’s most recent closing price. GE HealthCare’s board and management have unanimously recommended that shareholders decline the offer, warning that mini-tender offers often carry hidden fees, provide limited withdrawal rights, and may leave investors unable to sell their shares at fair market value. The company has engaged its legal and investor relations teams to communicate directly with institutional and retail shareholders, and has filed a formal notice with the Securities and Exchange Commission to highlight the offer’s potential risks. GE HealthCare holds a market capitalization exceeding $60 billion and trading volumes averaging more than 1.2 million shares per day, underscoring the limited scale and strategic irrelevance of a 100,000-share offer to its broad shareholder base.

GE HealthCare has entered a strategic collaboration with NXP Semiconductors to develop and showcase edge AI solutions for anesthesiology and neonatal intensive care at CES 2026. Leveraging NXP’s secure, low-latency processing and GE HealthCare’s $19.7 billion medical technology business, the partnership will unveil a voice-command interface for anesthesia delivery systems and an intelligent monitoring platform for NICU environments. Both concepts employ on-device neural processing units and the NXP eIQ AI Toolkit to ensure real-time data analysis while maintaining strict patient privacy—no images or data leave the device. These prototypes align with GE HealthCare’s Responsible AI principles, emphasizing safety, transparency, and explainability, and illustrate the company’s effort to enhance clinician productivity, reduce cognitive load and alarm fatigue, and potentially accelerate adoption of AI-enabled point-of-care devices across its 125-year heritage of medical innovation.